初级尿道癌:局部,晚期和转移性患者的治疗模式,反应和生存率
Ilfad Blazevic1, Aude Fléchon2, Géraldine Pignot3
1Oncopole Claudius Regaud Toulouse France.
BJUI compass
|July 21, 2025
概括
初级尿道癌 (PUC) 很少见,治疗方法和结果各不相同. 本研究详细介绍了当代PUC患者的治疗模式和生存率,特别是转移性疾病患者.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 癌症研究 癌症研究
背景情况:
- 初级尿道癌 (PUC) 是一种罕见的恶性瘤,对最佳治疗策略和生存率的数据有限.
- 对转移性PUC的最佳管理和预后因素仍然不太了解.
研究的目的:
- 描述治疗模式,响应率和存活结果,在当代一群初级尿道癌症患者.
- 为了分析转移性PUC患者的生存数据,将同步和超时病例组合起来以增加统计能力.
主要方法:
- 从2000年至2018年期间诊断的9家法国高等医疗中心回顾性数据收集.
- 包括局部,局部晚期和转移性疾病的患者,特别关注转移性病例的生存分析.
- 对同步和超时转移性转移性疾病的聚合分析,以增强对生存率评估的统计能力.
主要成果:
- 该队列包括71名患者,尿路细胞 (40.0%),状细胞 (34.3%) 和腺癌 (14.3%) 是常见的组织学.
- 在诊断时,35.2%的患者患有局部性疾病,49.3%的患者患有局部性疾病,15.5%的患者患有远程转移性疾病.
- 非转移性疾病的中位数无病生存 (DFS) 为21.2个月;结节参与恶化了DFS (HR:2.03,p=0.039). 转移性患者的平均整体存活时间为15.2个月,无进展存活时间为6.4个月.
结论:
- 初级尿道癌在组织学,诊断阶段和治疗方法方面表现出显著的异质性.
- 这项研究为转移性PUC的治疗和生存提供了宝贵的见解,这是数据稀缺的领域.
- 进一步的研究和改进的策略对于提高原发性尿道癌患者的生存结果至关重要,特别是在晚期.
更多相关视频
09:28Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
10.3K
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.3K
相关概念视频
01:17Urinary Tract Infection IV: Nursing Management
88
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
88
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
41
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
41
01:21Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
01:30Urinary Tract Calculi III: Medical Management
25
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
25
01:25Urinary Tract Calculi VI: Surgical Management
30
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
30
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K